about
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic ActivityDiscovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell modelsCannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysisStructural evolutions of salicylaldoximes as selective agonists for estrogen receptor betaConstruction and validation of a RET TK catalytic domain by homology modeling.Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis.Indoles and related compounds as cannabinoid ligands.Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.Identification of new Fyn kinase inhibitors using a FLAP-based approach.Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies.Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors.Synthesis and biological evaluation of non-glucose glycoconjugated N-hydroyxindole class LDH inhibitors as anticancer agents.Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.Investigating the binding mode of an inhibitor of the MBNL1·RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder.Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer CellsMolecular modeling of adenosine receptors: new results and trends.Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors.Computational approaches on angiotensin receptors and their ligands: recent developments and results.Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffoldsDocking-based virtual screening: recent developments.Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.CDK inhibitors: from the bench to clinical trials.Adenosine receptor ligands in clinical trials.Computational studies on translocator protein (TSPO) and its ligands.Computational approaches for the identification and optimization of Src family kinases inhibitors.Constituents of Polygala flavescens ssp. flavescens and Their Activity as Inhibitors of Human Lactate Dehydrogenase.Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15.Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.Cyclic Ketoximes as Estrogen Receptor β Selective Agonists.4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.Antibacterial and Hypoglycemic Diterpenoids from Salvia chamaedryoides.Identification and characterization of a new reversible MAGL inhibitor.Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.Human carbonyl reductase 1 as efficient catalyst for the reduction of glutathionylated aldehydes derived from lipid peroxidation.N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.α-Glucosidase and α-Amylase Inhibitors from Arcytophyllum thymifolium.
P50
Q27701780-5BC2BFBA-63AC-4456-8C53-037BF910DB34Q27704009-8316BABE-6EBF-41C7-B6AB-54F4A604D1CEQ28294951-4CA6DC76-197A-43D8-8F79-04EEA93D83A5Q28306027-D5AD65F8-302C-41A7-AD24-DA32FAE13B4BQ33273422-2F0CA725-E4A6-426A-A2DF-2C9E3C169D28Q33323622-C0ECF295-29BE-4AAF-8817-BFDC481C86D5Q33588831-1228BB70-023F-46C7-B0AC-CF8F32E1346CQ34712554-3BB4DBB0-F815-426C-803A-968621013E84Q34778147-E13CFE11-1025-4452-B2A1-57BB355B1BA6Q34930830-05C28511-68BA-4D6D-A59D-64661E62C4DAQ34977657-D81FA2C0-F40D-4C76-B496-0F015C52CF6EQ35248274-82213EEB-CE0D-49B3-839B-CE0BC434B7EEQ35617834-8615446F-2FE5-4590-8900-C210087CB5AEQ35836244-1021EA02-20BD-40B9-AC3E-52BACEE3051CQ36175547-8641336C-B67B-4F1F-95C2-C5774533C70CQ36546738-30055A2C-1ABA-4721-A38C-2D44BB4C584CQ36551125-05AF7CAA-7C52-4A31-830D-D236E90B2920Q36816987-7A242EF4-5D38-4598-A3ED-9495A7907226Q36879377-B40B7C24-8B70-42E0-9266-2EC432E7A167Q37066078-88FCD762-B61E-4B4F-BC96-FB30A2DFDD51Q37310087-72A3A624-0090-4AEF-83EA-BB8727CD729DQ37411223-94B7CE52-A5C5-463F-AF5A-C5ADE723043FQ37575221-57437E88-3414-4954-9E1F-ECCD717AF671Q37704499-D7C0C45A-8303-48C4-B2BD-3FCC2373017AQ37724963-507B0F89-1815-43E0-92C0-6CC1D93CB0C7Q37971992-C0AC7043-2795-46BC-B3EC-84B508789776Q38227410-77C0CC54-98F8-4387-8B6C-FB5DB7728F90Q38686527-31ED04FB-E35D-4976-A074-5B4D37475B0BQ38699260-1356BA89-9E96-4438-879A-40F24ABC2F32Q38715594-971F0BF1-77E4-4BAD-999F-13A1E253BD23Q38733280-B5642ADE-460C-4E42-89D2-2D5C3E58AD8CQ38773922-40E019BD-4A0A-4D2E-B6BA-2A2224102401Q38911009-5ED7F697-7EAD-46AC-A816-BDA2BDFD790FQ38967774-57B1591C-0017-4BD3-BE93-B38DF17806D1Q38992675-B2394824-2898-44AA-A227-A900F6CB6E91Q39066242-3C35EB8A-2FFD-4EF3-8930-D412B941D320Q39368198-4643FA92-C68F-4B36-91DA-74D82B26C159Q39452563-53953FE0-7957-4F58-A7C9-ED94DCFE4F10Q39468979-1518CF61-81F7-4324-8625-EE76D298D611Q39504055-475090A9-414D-44EA-9234-D908A28DE283
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tiziano Tuccinardi
@ast
Tiziano Tuccinardi
@en
Tiziano Tuccinardi
@es
Tiziano Tuccinardi
@nl
Tiziano Tuccinardi
@sl
type
label
Tiziano Tuccinardi
@ast
Tiziano Tuccinardi
@en
Tiziano Tuccinardi
@es
Tiziano Tuccinardi
@nl
Tiziano Tuccinardi
@sl
prefLabel
Tiziano Tuccinardi
@ast
Tiziano Tuccinardi
@en
Tiziano Tuccinardi
@es
Tiziano Tuccinardi
@nl
Tiziano Tuccinardi
@sl
P1053
M-1232-2015
P106
P1153
6507524571
P21
P2456
P2798
P31
P3829
P496
0000-0002-6205-4069